| Bioactivity | Mal-PEG8-Val-Cit-PAB-MMAF is a drug-linker conjugate for ADC. Mal-PEG8-Val-Cit-PAB-MMAF contains a cleavable ADC linker and a potent tubulin inhibitor MMAE (HY-15162)[1]. | ||||||||||||
| Name | Mal-PEG8-Val-Cit-PAB-MMAF | ||||||||||||
| Formula | C81H129N11O24 | ||||||||||||
| Molar Mass | 1640.95 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337. |
Mal-PEG8-Val-Cit-PAB-MMAF
CAS: F: C81H129N11O24 W: 1640.95
Mal-PEG8-Val-Cit-PAB-MMAF is a drug-linker conjugate for ADC. Mal-PEG8-Val-Cit-PAB-MMAF contains a cleavable ADC linker
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.